Molecular Biomarker of Drug Resistance Developed from Patient-derived Organoids Predicts Survival of Colorectal Cancer Patients

Published: 8 December 2021| Version 2 | DOI: 10.17632/rnrmjkvjjc.2
Contributors:
Lifeng Chen, Bo Tian, Wen Liu, Haitao Liang, Yong You, Weizhen Liu

Description

Figure S3. All enriched hallmark and KEGG pathways by using GSEA associated with 5-Fu resistance. Figure S4. Up and down-regulated hallmark and KEGG molecular pathways by using GSEA between DRS-high and DRS-low patients in TCGA-CRC cohort.

Files

Institutions

Wuhan Union Hospital

Categories

Drug Resistance in Cancer, Organoid

Licence